Envestnet Asset Management
LABD icon

Envestnet Asset Management’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Envestnet Asset Management’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,127
Closed -$84.3K – 4596
2025
Q2 		$84.3K Buy
+1,127
New +$99.7K ﹤0.01% 4356

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Envestnet Asset Management's LABD Position: Q3 2025 in Review

Envestnet Asset Management sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2025, closing a stake of 1,127 shares — an estimated $84.3K sold.

Envestnet Asset Management first reported a position in LABD in Q2 2025 and held it in 1 quarter. The position peaked at $84.3K in Q2 2025. 18 funds tracked by Wall St. Rank hold LABD as of Q3 2025.

  • Envestnet Asset Management reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 1,127 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2025, an estimated $84.3K.
  • Envestnet Asset Management first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2025 and held it in 1 quarter.
  • Envestnet Asset Management's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $84.3K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2025.

Based on Envestnet Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.